Topper David Joseph
Insider CIK 1740378 · EGL Director, 10% owner · ARQT Chief Financial Officer · FLAC Chief Financial Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARQT Arcutis Biotherapeutics, I | S Sale | 2025-04-02 | 2025-04-03 | 9,600 | $15.80 | $151.7K | 182,774 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2025-02-28 | 2025-03-04 | 89,000 | — | $0 | 89,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2025-02-28 | 2025-03-04 | 34,000 | — | $0 | 192,374 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2024-09-24 | 2024-09-25 | 11,626 | $9.48 | $110.2K | 158,374 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-09-21 | 2024-09-25 | 60,000 | — | $0 | 170,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award deriv | 2024-04-10 | 2024-04-11 | 310,000 | — | $0 | 310,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | A Award | 2024-04-10 | 2024-04-11 | 110,000 | — | $0 | 110,000 | SEC↗ |
| FLAC Frazier Lifesciences Acqui | M Exercise deriv | 2022-11-22 | 2022-11-23 | 30,000 | — | $0 | 0 | SEC↗ |
| EGL Engility Holdings, Inc. | D To issuer | 2019-01-14 | 2019-01-14 | 8,960,446 | — | $0 | 0 | SEC↗ |